Skip To Content
JEWISH. INDEPENDENT. NONPROFIT.
Breaking News

Ryan Braun Wins Appeal of Drug Ban

?Hammer? Is Back: Ryan Braun, the first Jewish most valuable player in 50 years, won his appeal of a suspension for performance-enhancing drugs. Image by getty images

National League Most Valuable Player Ryan Braun won his appeal of a suspension imposed after he allegedly failed a test for performance-enhancing drugs, the baseball players union announced Thursday.

The Milwaukee Brewers slugger, the first Jewish MVP in a half-century, became the first baseball player ever to successfully appeal a positive drug test.

“I am very pleased and relieved by today’s decision,” Braun said in a statement, ESPN reported. “It is the first step in restoring my good name and reputation. We were able to get through this because I am innocent and the truth is on our side.

“I have been an open book, willing to share details from every aspect of my life as part of this investigation, because I have nothing to hide,” added Braun, 28. “I have passed over 25 drug tests in my career, including at least three in the past year.”

Braun, who was named to the Forward 50 list of influential Jews for 2011, would have been suspended for 50 games.

He tested positive for elevated levels of testosterone, usually considered a telltale sign of performance-enhancing drugs. An arbitration panel ruled 2-1 in his favor, without giving any reasoning.

Braun hit .312 with 33 homers and 111 RBIs last year and led Milwaukee to the National League championship series.

Braun, whose father’s family is Jewish, did not grow up in an observant Jewish home but has enthusiastically embraced his jewish roots.

A message from our CEO & publisher Rachel Fishman Feddersen

I hope you appreciated this article. Before you go, I’d like to ask you to please support the Forward’s award-winning, nonprofit journalism during this critical time.

We’ve set a goal to raise $260,000 by December 31. That’s an ambitious goal, but one that will give us the resources we need to invest in the high quality news, opinion, analysis and cultural coverage that isn’t available anywhere else.

If you feel inspired to make an impact, now is the time to give something back. Join us as a member at your most generous level.

—  Rachel Fishman Feddersen, Publisher and CEO

With your support, we’ll be ready for whatever 2025 brings.

Republish This Story

Please read before republishing

We’re happy to make this story available to republish for free, unless it originated with JTA, Haaretz or another publication (as indicated on the article) and as long as you follow our guidelines. You must credit the Forward, retain our pixel and preserve our canonical link in Google search.  See our full guidelines for more information, and this guide for detail about canonical URLs.

To republish, copy the HTML by clicking on the yellow button to the right; it includes our tracking pixel, all paragraph styles and hyperlinks, the author byline and credit to the Forward. It does not include images; to avoid copyright violations, you must add them manually, following our guidelines. Please email us at [email protected], subject line “republish,” with any questions or to let us know what stories you’re picking up.

We don't support Internet Explorer

Please use Chrome, Safari, Firefox, or Edge to view this site.